glutathione iv fort tadive dyski esia tardive_dyskinesia [TUSOM Treatment of Tardive Dyskinesia |
Description
Sep 2017;112(9):1448-1456
Branco, A.C.C.C., Yoshikawa, F.S.Y., Pietrobon, A.J., Sato, M.N
doi: 10.5402/2012/346297
20,21 Recent data show that beneficial clinical responses to naltrexone might involve antagonism of -opioid receptors by reducing dysphoria, anxiety, and drug-seeking behaviors
2020;15, (1):e0227887
Considering the cell-harvesting aspect, it is difficult to apply other cell types on a large scale except BMSCs and ADSCs
